NCT05224297 Patient Experience Data in Radiation Oncology
| NCT ID | NCT05224297 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Vienna |
| Condition | Radiotherapy Side Effect |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2020-10-01 |
| Primary Completion | 2025-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2020-10-01 with a primary completion date of 2025-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The project is part of the overarching goal of improving patient-centric radiation oncology. This pilot project aims to develop an instrument that can be used to collect clinically relevant patient-reported outcome data on adverse effects during and after RT. This real-world evidence (RWE) database will be the basis to monitor and evaluate future technological developments, combination treatments (e.g. radioimmunotherapy, etc.), or changes in treatment protocols. The pseudonymized data will be linked to data in the oncological information system and dosimetric data from the treatment planning system. In this way, they represent a basic building block of patient-oriented development of clinical radiotherapy.
Eligibility Criteria
Inclusion Criteria: * all patients receiving external beam radiotherapy Exclusion Criteria: * unable to independently answer questionnaires on radiation-induced side effects
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05224297 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Radiotherapy Side Effect. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05224297 currently recruiting?
Yes, NCT05224297 is actively recruiting participants. Contact the research team at gerd.heilemann@meduniwien.ac.at for enrollment information.
Where is the NCT05224297 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT05224297 clinical trial?
NCT05224297 is sponsored by Medical University of Vienna. The trial plans to enroll 6,000 participants.